Display Settings:

Format

Send to:

Choose Destination
    HNO. 2012 Jan;60(1):41-3.

    [Dysplasia and laryngeal carcinoma in situ].

    [Article in German]

    Source

    Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde & Plastische Operationen, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23583, Lübeck, Deutschland. ursula.schroeder@uksh.de

    Abstract

    Although the glottis is amenable to chemotherapy, currently most lesions from stage I laryngeal dysplasia up to carcinoma in situ are excised. This literature review presents selected molecular biological aspects especially in relation to dysplasia of the larynx and its therapy, as well as currently preferred biomarkers for chemotherapeutic prevention of laryngeal dysplasia.

    PMID:
    22282009
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk